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Summary The antitumor effect of Coηnebαcterium kuおcheriwas evaluated in mice 
by the administration of formalin目killedwhole cel (FK-CK) or subcellular fraction named 
CK・m (mitogen derived from C. kutscheri). In these studies， two systems of mouse vs 
tumor cel (outbred ddY vs Ehrlich ascites carcinoma cell， inbred CDF1 vs P 3881eukemia 
cel) were used. Treatrrient of mice in the dose range of greater than 106 bacterial cells or 
20μg of CK.m per mouse conferred substantial protection on both mice. The enhanced 
cytotoxicity of peritoneal exudate cells played a leading role in the initial phase of 
antitumor activity. The Winn assay disclosed that antitumor activity was attributable to 
nonadherent splenocytes whose activity was impaired by treatment with anti-T cel anti-
body and complement. The fact that the generation of effector cells paralleled that of the 
delayed-type hypersensitivity to this bacterium may suggest that the antitumor activity of 
C. kutscheri is mediated in part by T cell. 
The isolation and characterization of biological activities of the active component of C. 
kutscheri were attempted. The antitumor activity was confined to the subcellular particle 
fraction of this organism and associated with a molecule of glycoprotein nature (38，000 
Dalton) isolated from this fraction by affinity chromatography with Concanavalin A-
Sepharose 4 B. This substance exerted mitogenic effect on C 3 H/HeJ splenocytes and T 
cells and further exhibited antitumor activity on P 388 leukemia cel in CDF1 mice. The 
Winn assay disclosed that the antitumor activity induced by this material was dependent on 
L 3 T 4 T cels. Furthermore， both the mitogenic and antitumor activity of this moiety were 
resistant to heating at 1000C for 30 min or RNase digestion， but sensitive to trypsin diges-
tion， low or high pH. These results indicate that the antitumor activity of C. kutscheri is 
attributable to the heat-stable glycoprotein moiety which can directly stimulate T cells and 
macrophages. 
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用にのぞみこのディスク l枚をbrainheart infusion 
(BHI) broth (Difco Laboratorises， Detroit， Mich.， 
USA)l ml中に融解後， 1夜 37'Cで培養して後 decar目
boxylase (Sigma chemical Co.， St.Louis， Mo.)を0.01
% (w/v)添加した BHIbroth 11に接種し，3TC18時間
回転培養した.この培養液を 6，000rpm 30分の遠沈によ
り集菌し，滅菌 Hanks'balanced salt solution(HBSS) 
にて同様の遠心により 3回洗糠した.洗糠菌体をホノレマ
























HBSS 0.1 ml中に変量した FK・CKを加えたものを
ddYマウス腹腔内に注射し，その直後に 5X10'EACを
同ーマウスに注射し 90日間観察して生残率および




Sodium dodecyl sulfate(SDS)， 0.25 %， DNase (type 
1: Sigma) 2μg/mlおよび 10mMMgC12を含有した








析した.その内液を 2'C36，000 g， 1時閣の冷却遠沈に
より SDSを除去し凍結乾燥した標品を P画分として使
用した.前述の 90，000g 2時間の超遠沈の上清は充分透











なるように加え 4'C60分後に 25，000g 30分の遠沈によ
り得た沈澱を Tris-B.に溶解し同液で充分に透析した.
この透析内液l.5mlをMgC1210mMを含む同じ緩衝





















































































100μl 0 O'cells/ m l)の培養液(10% FCS， 10 mM  HEP 











種の ddYマウスは， 104個の FK・CKにより 45%の生残 ノレに達した.これに対し 10'個 EACのみを単独投与した
率が得られ， 10'個の FK・CKでは腫蕩接種 90日後にお 群においては，接種 3日後より細胞数の増加が著名とな
いて 90%のマウスが生残し，その MSTは73.6日であ り5日後には約 60倍に達し，その殆どが EACであるこ
った. P 388対 CDF，"<ウスの場合は FK・CK10'個投与 とが腹腔細胞の塗抹標本により確かめられた.
により 60日後における生残率は 60%， MSTは48.2日 Fig. 1に示す如く FK・CKのみの投与では，最初の 2
であり， 10'{固の投与によりそれぞれ 80%， 55.5日であ 日間の腹腔細胞の主成分は多核白血球(PMN)であり， 6 
った.104個の投与では対照群の 11.1日に比し 30.2日と 時間目から次第に増加して 12時間後に最高値を示し，以
なる程度で 60日後には全てのマウスは死亡した.これら 後次第に減少して数日間は尚かなりの割合を占めている
の結果から以下の実験は EAC-ddY系では 10'個を， P マクロアァージに関しては 24時間後より次第に増加し
388-CDF，では 10'個の FK'CKを使用するのが適当と 4日目で最高値を示し以後2週以上その値を持続したが，
思われた EAC5x10'個の単独接種では食細胞の反応は殆どみら
2.マウス腹腔内での抗腫蕩効果の発現 れなかった.なお CDF，対 P388系においても同様の傾
1)マウス腹腔内細胞の動態 向であった.
Table 2に示す如く 10'個の FK・CKのみを投与した のCDF，対 P388系の抗腫湯性
マウスにおいては約 6倍の細胞数の増加がみられたがそ この点に関しては FK・CK処置マウスの腹腔細胞
の増加は 72時間後に最高値を示した.一方 5x10'個の (PEC)を採取して培養し [3HJthymidineのDNAへの
EACを同時に投与した場合は 24時間後に最高値を示し 取り込みを指標に P388細胞の増殖の有無を検索した.
たが以後次第に減少して 3日後には FK.CKのみのレベ Table 3に示す如く P388をFK・CKと共に CDF，マウ
Table 1. Antitumor effect of FK・CKagainst EAC and P388 cells 
Numbers Antitumor effect* 。f
FK.CK 
EAC vs. ddY mice P388 vs. CDF， mice 
survival MST survival MST 
rate， % days rate， % days 
104 45 50目6 。 30.2 
10' 85 68.4 60 48.2 
108 90 73目6 80 55.5 
Control 15.4 。 11.1 
Each group consisted of 20 mice (ddY) or 10 mice (CDF，) and mice w巴re
challenged with 5 x 10' EAC cells (ddY mice) or with 10' P388 (CDF， mice)， 
immediat巴lyafter treatrent. Mice w巴rekept for 90 days (ddY mice) or 60 days 
(CDF， mice). Data were obtained from two separate experiments and expressed 
as the mean values of two experiments 
Table 2. Cellular respons巴sin the p巴riton巴alcavity 
Time Total c巴1numbers， X 10' /peritoneal cavity 
after 
10' FK・CK 10' FK.CK十 HBSS + injection， 




6 6.3土0.7 10.2士1.2 10.6士2.4
12 10.7士0.6 16.2土2.4 12.5土3.2
24 11.8土O目4 16.4士3.6 16.7士2.3
48 12.2土2.2 12.9土1.4 31.5土4.2
72 13.0士2目1 13.5:t2.4 37.3士5.1
96 12.7士2.3 12.9土1.1 46.8土6.3
120 11.5土0.9 11.6士1.3 59.6士8.4
Mice were inject巴dintrap巴ritoneallywith 10' FK・CK，10' FK.CK plus 
5 X 10' EAC or HBSS plus 5 X 10' EAC， sacrificed at indicat巴dtimes， and 
peritoneal cells were obained by lavage. Peritoneal cells yields are 
pr巴sentedas means土 SDfor 5 mice per time point 
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Fig. 1. Differential cell counts of host cells in the 
peritoneal cavity after injection of 5 X 10' 
EAC cells following 10' FK.CK treatment. 
The data are presented as PMN (・-・)/
mous巴 X10'， mean土 SD for 5 mice/tim巴
point， and as macrophages (O-O)/mouse x 
10'， mean士 SDfor 5 mice/time point. PMN 
(・…・)and macrophages (0…0) in control 
mice receiving HBSS and 5 X 10' EAC cells. 






ddYマウス 10匹づっの腹腔内に 5X10'個の EACを接
種し，接種直後にそれぞれの画分の表示量を静脈内に注
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Fig. 2. Cytotoxic activity of PEC obtained from 10' 
FK.CK-treated mic巴 toP388 (0) or YAC-1 
(e) cells as determined by the 4-hour 51Cr 
releas巴 assay(E: T ratio二 50: 1). Data were 
obtained from three different experiments 
and巴xpressedas mean土 SDfor triplicate 
cultur巴s.Cytotoxicity of HBSS-induced PEC 
in control mic巴・ 4.8土 0.2%to Y AC-1 cells， 
5.4 :t 1.1% to P388 cells. 
Table 3. Measurement of P388 growth in PEC obtained from mic巴
inoculat巴dwith FK'CK and P388 c巴ls
PEC obtained" 
from mice 
Incorporation of [3HJTdR， mean cpm土 SD/culture
injected with 24 h 48 h 72 h 
FK 'CK and P388 00') 14，500土3，720b 9，240土l，780b
HBSS and P388 00') 22，250土6，730 28，600士7，400
FK'CK 920士 340 2，040土 870
HBSS 756土 214 840土 180










a. Mice were challe泊g巴dwith 10' P388 tumor cells intraperiton巴allyand peritoneal cells w巴r巴 obtainedby lavage at 
indicated times. P巴ritonealcells OO'/wel) w巴recultur巴dat 3TC in 5% CO， for 18 h and puls巴dwith 1μCi [3HJTdR 
during th巴 last6 h， Culture of P388 tumor cells (10'/wel) served as positive contro1. Data were obtained from three 
dif巴rentexp巴rimentsand巴xpressedas mean土 SDfor triplicate cultures 
b. Different from control (HBSS and P388-injected) ; P < 0.05 
c. Diff巴rentfrom control (HBSS and P388-injected) ; PくO目。1
寛七田原(104) 
Table 5. Antitumor eff巴ctof巴achfraction after 
inoculation of 5 x 10' EAC cells 
Table 4. NK activity of splenic nonadherent 














Data were obtained from two separat巴experimentsand 
expressed as the mean value of two experiments. Statisti. 
cally not significant when survival rate was 15% or less 
by Fish巴r'stest for 2 x 2 tables. Numbers in parentheses 
indicate MST. Survival rate of untr巴at巴dcontrol groups 
was 0 %， and MST was 16.2 days. 
a. Groups of 10 mice (ddY) were challenged intraper. 
itoneally with 5 x 10' EAC cells and immediately 
injected intravenously with graded dos巴sof each frac-
















a. Splenic nonadherent cells enriched by nylon wool 
columns (were mixed with 5lCr-labeled P388 tumor 
cells (E: T ratio = 50 : 1). Cytコtoxicitywas measured 
by the 4 hour Cr releas巴 assay. Data was obtained 
from three different experiments and expressed as 
mean士 SDfor thre巴 cultures
b. The number of effectors was adjusted to achi巴vethe 
E : T ra tio of 50 : 1 after c巴lIsw巴r巴treated wi th anti 
-asialo-GM1 and complement. 
c. Statistically significant (P < 0.01) by Student's t test， 

















































































Fig. 3. c. 10% SDS-PAGE of 
CK・min the pr巴sence
of 2ME. The molecu 
lar weight was巴sti.




Fig. 3. b. The molecular 
w巴ightof th巴 second
peak was estimated 




bovine serum albumin 
(BSA ; 66，000) cyto 
chrome C (Cyt C; 
12，400). V巴ニElution
volume (75 ml) ; V 0ニ
void volum巴 (48ml) 
1.5 
Fig. 3. a目 Chromatographic separa-
tion of the ammonium-sulfate-
precipitated P fraction on a 
column (2 x 55 cm) of Sepha-
cryl S-300 preequilibrated 
with Tris-buffer containing 
10 mM  MgCl，. A 5-ml frac 
tion was collect巴d，and the 
optical density at 280 nm (0)， 
and mitogenic activ-ity on C3 
H/HeJ splenocytes (e) were 
m巴asured.




分を Tris-Bに溶解し Tris-B.で、透析した内液を Sepha
cryl S-300のカラム (2X55cm)を通過させた.
Fig. 3 aに示す如く 280nmの吸光度により 3つのピ
601 
J. Con A司activated
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Fig. 4. Blastogenic responses of splenocytes and 
splenic T ce11s (C 3 H/HeJ) to graded doses 
of CK'm. Ce11s (2 x 105) in 100μ1 of com-
plete medium were stimulated with an equal 
volume of CK'm solution at 3TC in a 5% CO， 
incubator for 72 h. Each point represents th巴
mean value of five cultures. 
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Fig. 5. Antitumor eff巴ctof CK'm. Groups of 10 mice 
were injected intrav巴nouslywith indicated 
doses of CK・m immediat巴lyafter intraper-
itoneal inoculation of 5 x 10' EAC c巴l1sto 
ddY mouse or 10' P388 ce11s to CDF1 mouse. 
Survival rate was d巴terminedat 60 days aft巴r
inoculation. The survival curves of CDF1 
mice inoculat巴dintravenously with 10' P388 
for 10μg and 20μg ar巴 shownin the middle. 
The curv巴 for10μg was compared to the 






較して 38，000 ~40 ， 000と推定された(3b). さらに数回
のゲノレ鴻過によってこのピ-'7を集め濃縮して ConA 
Sepharos巴(Pharmacia)カラムに吸着させ， 0.3M a 
methyl-D-mannosideおよび 0.15M galactoseで溶出
した. この溶出液を蒸留水に透析し凍結乾燥したものを
CK • m (c. kutscheri由来の mitogen)と命名した. この
CK'mをさらに SDS・PAGE15)により分子量を測定した
ところ Fig.3 cに示す如く約 38，000Daであることが
明かとなった.
5. CK'mのmitogenj舌1










時に ddYマウスには EAC5X10'個を， CDF1マウスには




Table 6. Generation of the antitumor eff巴ct in 
splenocytes from CDF1 mic巴 treat巴dwith 
CK'm 
Days aft巴r Antitumor ef巴cta
treatment survival rate， % MST 
-1 (control) 。 10.7 
2 10 14.6 
4 5b 20.8 
6 80' 25.6 
12 85 27目4
a. CDF， mice were intravenously inject巴dwith 20μg of 
CK 'm， and splenocytes were obtained at indicated days 
Groups of 10 mice received intraperitoneally th巴admix
ture of 107 splenocytes and 10' P388 cels. Data are 
presented as the mean survival rate of mice at 60 days 
after inoculation and also as MST of mice dying of 
tumor growth. Results are expressed as average value 
of two separa te experiments. 
b. Different from control ; P < 0.05. 





与し， Table 6に示す日数の後，牌細胞を採取しその 10'








































Tabl巴 7目 Effectorcells in the antitumor effect in同
duced by CK・m as d巴terminedby the Winn 
test 
Treatment Winn assay' 
of 
splenocytes 巴xp.1 exp. 2 
Anti-Lyt 2 Ab+C 7/10b 9/10 
Anti-L 3 T 4 Ab+C 1/10 。/10
Anti-asialo GM1 Ab十C 7/10 7/10 
Anti-macrophages Ab十C 7/10 7/10 
9/10 8/10 
Control group 0/10 。/10
a. Winn assay expressed as number of survivors/number 
of mice tested. Spleen cells obtained 10 days after 
treatment with 20μg of CK'm were treated with in-
dicated antibodies and complement; 106 P388 tumor 
cells were admixed with 10' treated effectors and imme-
diately injected intraperitoneally into naive CDF 1 mice 
(10 mice/group). The number of survivors was deter 
mined at 60 days after inoculation. 
b. Pく0.01，as determined by Fish町、 testfor 2 x 2 
tables. 
Table 8. Biochemical properties of the mitogenic 
and antitumor activities of CK'm 
Treatment 
Biological activitie;: 
mitogenicity' antitumor effectb 
None 52.126士3，452 90 (56.4) 
RNas巴 53，017土2，138 85 (50.6) 
Trypsin 1，134士 214 日06.8)
100"C， 30 min 47，378土2，649 80 (48.8) 
pH 2 6，536士1，208 。06.4)
pH 12 1，118土 863 。05.5)
a. As det巴rminedby incorporated [3HJTdR after a 
72-hour-culture of C 3 H/HeJ spenocytes (2 x 105/ 
well) with 500 ng/ml of treated CK 'm. Data were 
obtained from two separate experiments. Resulst are 
expressed as mean土 SEfor 6 cultures. Cul tures of 
spl巴nocyteswith Con A (2μg/ml : 53，426土 4，635;cul-
tures of splenocytes without stimulat巴d:856士 232)
b. As determined by th巴survivalrates of ddY mice inject-
巴dwith 20μg of tr巴atedCK"m after an intraperitoneal 
inoculation of 5 x 106 EAC. Each group consisted of 10 
mice. Data were obtained from two s巴parateexperi. 
ments. Results ar巴expressedas the mean of two experi 










4 6 8 
Days afteri吋ection
Fig. 6目 Generationof DTH in mice treat巴dwith 106 
FK.CK. Group of 5 mice w巴re!ilJ巴ct巴dintra-
peritoneally with 106 FK'CK and delay巴d
footpad response to FK.CK antigens was 
done at 2-days intervals. Th巴 data are 
























































を行い， 90，000 g 2時間の超遠沈により得た微小穎粒画
分(P画分〕を材料として硫安分画， S巴phacrylS-300に
よるゲノレ櫨過，さらに ConA -sepharoseによる affinity
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